BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23595577)

  • 1. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
    Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
    Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
    Wang G; Ahmad KA; Ahmed K
    Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer.
    Li Q; Li K; Yang T; Zhang S; Zhou Y; Li Z; Xiong J; Zhou F; Zhou X; Liu L; Meng R; Wu G
    Sci Rep; 2017 Nov; 7(1):16134. PubMed ID: 29170453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
    Ruzzene M; Penzo D; Pinna LA
    Biochem J; 2002 May; 364(Pt 1):41-7. PubMed ID: 11988074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK2 inhibition induces apoptosis via the ER stress response.
    Hessenauer A; Schneider CC; Götz C; Montenarh M
    Cell Signal; 2011 Jan; 23(1):145-51. PubMed ID: 20807566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway.
    Li L; He D; He H; Wang X; Zhang L; Luo Y; Nan X
    Cancer Lett; 2006 May; 236(2):259-68. PubMed ID: 16216409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 and PML: regulating the regulator.
    Lallemand-Breitenbach V; de Thé H
    Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML.
    Yang B; Yao J; Li B; Shao G; Cui Y
    Mol Cell Biochem; 2017 Dec; 436(1-2):87-97. PubMed ID: 28744813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.
    Chatterjee A; Chatterjee U; Ghosh MK
    Cell Death Dis; 2013 Mar; 4(3):e543. PubMed ID: 23492774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation.
    Lin YC; Hung MS; Lin CK; Li JM; Lee KD; Li YC; Chen MF; Chen JK; Yang CT
    Cancer Biother Radiopharm; 2011 Jun; 26(3):381-8. PubMed ID: 21711111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome c-mediated apoptosis in human lung cancer A549 cells.
    Oh HL; Lee DK; Lim H; Lee CH
    J Ethnopharmacol; 2010 May; 129(1):135-9. PubMed ID: 20219657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases.
    Kimura C; Zhao QL; Kondo T; Amatsu M; Fujiwara Y
    Exp Cell Res; 1998 Mar; 239(2):411-22. PubMed ID: 9521859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
    Quotti Tubi L; Gurrieri C; Brancalion A; Bonaldi L; Bertorelle R; Manni S; Pavan L; Lessi F; Zambello R; Trentin L; Adami F; Ruzzene M; Pinna LA; Semenzato G; Piazza F
    J Hematol Oncol; 2013 Oct; 6():78. PubMed ID: 24283803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.